Immunocytochemical Evidence on the Effects of Glucocorticoids on Type I Collagen Synthesis in Human Osteoblastic Cells

Calcified Tissue International

Volumn 74, Issue 3, 2004, Pages 284-293

  Hernandez M V ^b   Guanabens N ^a   Alvarez, L ^a   Monegal, A ^a   Peris, P ^a   Riba, J ^a   Ercilla, G ^a   Martinez De Osaba M J ^a   Munoz Gomez J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

Immunoperoxidase type I antiprocollagen antibody dexamethasone; Procollagen type I C propeptide (PICP); Procollagen type I N propeptide (PINP)

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; DEXAMETHASONE; GLUCOCORTICOID; PEROXIDASE; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN N PROTEINASE;

CELL CULTURE; CELL FUNCTION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; CULTURE MEDIUM; DIAGNOSTIC VALUE; DNA SYNTHESIS; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; OSTEOBLAST; PRIORITY JOURNAL; RELIABILITY;

ALKALINE PHOSPHATASE; CELLS, CULTURED; COLLAGEN TYPE I; DEXAMETHASONE; DNA; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; OSTEOBLASTS; PEPTIDE FRAGMENTS; PROCOLLAGEN;

EID: 17944399162     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-002-1095-5     Document Type: Conference Paper

References (36)

1. Patschan D, Loddenkemper K, Buttgereit F (2001) Molecular mechanisms of glucocorticoid-induced osteoporosis. Bone 29:498-505
2. Carbonare LD, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ (2001) Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 16:97-103
3. Lems WF, Gerrits MI, Jacobs JWG, van Vugt RM, van Rijn HJM, Bijlsma JWL (1996) Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis 55:288-293
4. Canalis E, Giustina A (2001) Glucocorticoid-induced osteoporosis: summary of a workshop. J Clin Endocrinol Metab 86:5681-5685
5. Chen TL, Cone CM, Feldman D (1983) Glucocorticoid modulation of cell proliferation in cultured osteoblast-like bone cells: differences between rat and mouse Endocrinology 112:1739-1745
6. Jonsson KB, Frost A, Larsson R, Ljunghall S, Ljunggren Ö (1997) A new fluorometric assay for determination of osteoblastic proliferation: effects of glucocorticoids and insulin-like growth factor-I. Calcif Tissue Int 60:30-36
7. Kasperk C, Schneider U, Sommer U, Niethard F, Ziegler R (1995) Differential effects of glucocorticoids on human osteoblastic cell metabolism in vitro. Calcif Tissue Int 57:120-126
8. Walsh S, Jordan GR, Jefferiss C, Stewart K, Beresford JN (2001) High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid-induced osteoporosis. Rheumatology 40:74-83
9. Wong MM, Rao LG, Ly H, Hamilton L, long J, Sturtridge W, McBroom R, Aubin JE, Murray TM (1990) Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells. J Bone Miner Res 5:803-813
10. Chevalley T, Strong DD, Mohan S, Baylink DJ, Linkhart TA Evidence for a role for insulin-like growth factor binding proteins in glucocorticoid inhibition of normal human osteoblast-like cell proliferation.
11. Canalis E (1983) Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology 112:931-939
12. Canalis E, Avioli L (1992) Effects of deflazacort on aspects of bone formation in cultures of intact calvariae and osteoblast-enriched cells. J Bone Miner Res 7:1085-1092
13. 3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses. Endocrinology 118:250-259
14. Chyun YS, Kream BE, Raisz LG (1984) Cortisol decreases bone formation by inhibiting periosteal cell proliferation. Endocrinology 114:477-480
15. Dietrich JW, Canalis EM, Maina DM, Raisz LG (1979) Effects of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 104:715-721
16. Hahn TJ, Westbrook SL, Halstead LR (1984) Cortisol modulation of osteoblast metabolic activity in cultured neonatal rat bone. Endocrinology 114:1864-1870
17. Hodge BO, Kream BE (1988) Variable effects of dexamethasone on protein synthesis in clonal rat osteosarcoma cells. Endocrinology 122:2127-2133
18. Nacher M, Serrano S, Mariñoso ML, García MC, Bosch J, Diez A, Lloreta J, Aubia J (1999) In vitro synthesis of type I collagen: quantification of carboxyterminal propeptide of procollagen type I versus tritiated proline incorporation. Calcif Tissue Int 64:224-228
19. Braidman IP, Hainey L, Batra G, Selby PL, Saunders PTK, Hoyland JA (2001) Localization of estrogen receptor β protein expression in adult human bone. J Bone Miner Res 16:214-220
20. Nakase T, Miyaji T, Kuriyama K, Tamai N, Horiki M, Tomita T, Myoui A, Shimada K, Yoshikawa H (2001) Immunohistochemical detection of parathyroid hormone-related peptide, Indian hedgehog, and patched in the process of endochondral ossification in the human. Histochem Cell Biol 116:277-284
21. Gehron Robey P, Termine P (1985) Human bone cells in vitro. Calcif Tissue Int 37:453-460
22. Smith E, Redman RA, Logg CR, Coetzee GA, Kasahara N, Frenkel B (2000) Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. J Biol Chem 275:19992-20001
23. Smith E, Coetzee GA, Frenkel B (2002) Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3β. J Biol Chem 277:18191-18197
24. Gronowicz GA, McCarthy M-B (1995) Glucocorticoids inhibit the attachment of osteoblasts to bone extracellular matrix proteins and decrease β1-integrin levels. Endocrinology 136:598-608
25. Gohel A, McCarthy M-B, Gronowicz G (1999) Estrogen prevents glucocorticoid-induced apoptosis in osteoblast in vivo and in vitro. Endocrinology 140:5339-5347
26. Weinstein RS, Jilka RL, Parfitt M, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 102:274-282
27. Jonsson KB, Ljunghall S, Karlström O, Johansson AG, Mallmin H, Ljunggren Ö (1993) Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human osteoblasts. Biosci Rep 13: 297-302
28. Oikarinen A, Autio P, Vuori J, Väänänen K, Risteli L, Kiistala U, Risteli J (1992) Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen. Br J Dermatol 126:172-178
29. Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A, Risteli J (1996) Immunoassay for intact aminoterminal propeptide of human type I procollagen. Clin Chem 42:947-954
30. Crowley S, Trivedi P, Risteli L, Risteli J, Hindmarsh PC, Brook CG (1998) Collagen metabolism and growth in prepuberal children with asthma treated with inhaled steroids. J Pediatr 132:409-413
31. Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A (1998) Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment. Am J Respir Crit Care Med 158:1432-1441
32. Palosaari H, Tasanen K, Risteli J, Larmas M, Salo T, Tjaderhane L (2001) Baseline expression and effect of TGF-beta 1 on type I and III collagen mRNA and protein synthesis in human odontoblasts and pulp cells in vitro. Calcif Tissue Int 68:122-129
33. Alvarez L, Peris P, Pons F, Guañabens N, Herranz R (1997) Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity. Arthritis Rheum 40:461-468
34. Suvanto-Luukkonen E, Risteli L, Sundström H, Penttinen J, Kauppila A, Risteli J (1997) Comparison of three serum assays for bone collagen formation during postmenopausal estrogen-progestin therapy. Clin Chim Acta 266:105-116
35. Tähtela R, Turpeinen M, Sorva R, Karonen S-L (1997) The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects. Clin Biochem 30:35-40
36. Risteli J, Risteli L (1997) Assays of type I procollagen domains and collagen fragments: problems to be solved and future trends. Scand J Clin Invest 57:105-113